News

The company said the intermediates will initially be used as active pharmaceutical ingredients in some of its drugs derived from petroleum products, reports Business Standard. The intermediates facility,

Daikyo Seiko, West’s partner, developed these technologies, which are based on a polymeric container, utilizing elastomeric components with Flurotec barrier film, and provided in a sterile, validated, ready-to-fill

Under the collaboration, GSK acquired exclusive rights to research and develop certain vaccine and inhaled product candidates using Liquidia’s proprietary Particle Replication In Non-Wetting Templates (PRINT) technology. The

The patent entitled, Small-Volume Oral Transmucosal Dosage Forms, describes a method of treating pain by administering a small-volume solid tablet containing sufentanil by adhering to the oral mucosa.

The double-masked study treated nine patients with severe dry eye with RGN-259 or vehicle control six times daily over a period of 28 days. RGN-259 met key efficacy

The solution enhances Discovery Studio’s portfolio of small-molecule ligand design and market-leading biological simulation tools. The software works on a spatial aggregation propensity algorithm and Developability Index issued

The software has been developed in collaboration with several companies from different industries where crystallisation processes,including precipitation plays a key role. The technology provides an integrated, easy-to-use, drag

Gross proceeds from the sale totaled $55m, while InterMune is eligible to gain a two-year royalty stream based on net sales of Actimmune. InterMune chairman, chief executive officer

The service leverages Illumina’s new HiSeq 2500 sequencing system, which is capable of sequencing a complete human genome in one day. Illumina president and chief executive officer Jay